SUBSCRIBE
SUBSCRIBE
News   Deals

Synthes, Inc. Confirms in Deal Talks with Johnson & Johnson for Potential $20 Billion Deal

April 18, 2011 | 
1 min read
ZURICH (Reuters) - Synthes said on Monday it was in takeover talks with Johnson & Johnson after reports the U.S. group is looking to buy the Swiss medical device maker for about $20 billion.
Mergers & acquisitions Europe
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration
Mergers & acquisitions
Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy
March 6, 2026
 · 
1 min read
 · 
Annalee Armstrong
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Cardiovascular disease
Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets
March 5, 2026
 · 
2 min read
 · 
Heather McKenzie
Businessman receiving large stacks of money from a giant hand. Concept of funding, venture capital, financial support, dividend, and profitable business.
Funding
Teva Bags $400M Backing From Blackstone To Advance Sanofi-Partnered Drug
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Reaching an agreement. Businessmen shake hands and make a deal. vector
Immunology and inflammation
Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac